Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Plager

Showing results (1-10 of 341) with videos related to

Pageof 35
Sort By:
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 1, 1977
Bone sarcomas: clinical experienceJ G Sinkovics, C Plager
Archives of Internal Medicine|February 1, 1980
Hemochromatosis and Listeria infectionJ G Sinkovics, F Cormia, C Plager
Annals of Internal Medicine|June 1, 1979
Eikenella corrodens as pathogenJ G Sinkovics, C Plager, K Mills
American Journal of Clinical Oncology|December 1, 1995
Myxoid malignant fibrous histiocytoma: experience with chemotherapyS R Patel, C Plager, N E Papadopoulos, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1986
Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patientsM Talpaz, C Plager, J Quesada, et al.
The Cancer Journal From Scientific American|February 11, 1998
Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experienceS S Legha, S Ring, O Eton, et al.
Cancer Treatment Reports|November 1, 1979
Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group StudyM K Samson, L H Baker, R S Benjamin, et al.
Cancer|November 15, 1989
A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanomaS S Legha, S Ring, N Papadopoulos, et al.
Oncology Reports|June 16, 2000
A phase II evaluation of bexarotene (Targretin) capsules in patients with metastatic melanomaA Y Bedikian, C Plager, N Papadopoulos, et al.
Cancer|January 1, 1996
Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanomaS S Legha, M A Gianan, C Plager, et al.
Pageof 35

Showing results (1-10 of 341) with videos related to

Sort By:
Pageof 35
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 1, 1977
Bone sarcomas: clinical experienceJ G Sinkovics, C Plager
Archives of Internal Medicine|February 1, 1980
Hemochromatosis and Listeria infectionJ G Sinkovics, F Cormia, C Plager
Annals of Internal Medicine|June 1, 1979
Eikenella corrodens as pathogenJ G Sinkovics, C Plager, K Mills
American Journal of Clinical Oncology|December 1, 1995
Myxoid malignant fibrous histiocytoma: experience with chemotherapyS R Patel, C Plager, N E Papadopoulos, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1986
Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patientsM Talpaz, C Plager, J Quesada, et al.
The Cancer Journal From Scientific American|February 11, 1998
Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experienceS S Legha, S Ring, O Eton, et al.
Cancer Treatment Reports|November 1, 1979
Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group StudyM K Samson, L H Baker, R S Benjamin, et al.
Cancer|November 15, 1989
A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanomaS S Legha, S Ring, N Papadopoulos, et al.
Oncology Reports|June 16, 2000
A phase II evaluation of bexarotene (Targretin) capsules in patients with metastatic melanomaA Y Bedikian, C Plager, N Papadopoulos, et al.
Cancer|January 1, 1996
Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanomaS S Legha, M A Gianan, C Plager, et al.
Pageof 35